[HTML][HTML] Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - Molecules, 2021 - mdpi.com
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi.

LS Lara, GC Lechuga, CDS Moreira… - Molecules (Basel …, 2021 - europepmc.org
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - Molecules - search.proquest.com
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CDS Moreira… - Molecules (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

[HTML][HTML] Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - Molecules, 2021 - ncbi.nlm.nih.gov
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi.

LS Lara, GC Lechuga, CS Moreira, TB Santos… - …, 2021 - search.ebscohost.com
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

[PDF][PDF] Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - … - pdfs.semanticscholar.org
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - 2021 - arca.fiocruz.br
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

[PDF][PDF] Optimization of 1, 4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - Molecules - academia.edu
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Optimization of 1,4-naphthoquinone hit compound: a computational, phenotypic, and in vivo screening against Trypanosoma cruzi.

LS Lara, GC Lechuga, CS Moreira, TB Santos… - 2021 - cabidigitallibrary.org
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …